AFC-HD AMS Life Science Co. Ltd. (2927.TO)
Japan
Year Ended August 31
GROUP 2025 2024
Revenue Y32.66 bln Y30.19 bln
Operating Profit Y2.41 bln Y1.92 bln
Pretax Profit Y2.44 bln Y1.92 bln
Net Profit Y1.45 bln Y1.25 bln
Per share
Earnings Y102.98 Y89.20
Diluted Earnings Y102.97 Y89.11
Results are based on Japanese accounting standards.
(END) Dow Jones Newswires
AFC-HD AMS Life Science Co. Ltd. also released the following forecasts:
GROUP 1st Half To Year Ending
Feb 2026 Aug 2026
Revenue Y16.73 bln Y34.14 bln
Operating Profit Y1.30 bln Y2.55 bln
Pretax Profit Y1.33 bln Y2.45 bln
Net Profit Y883.00 mln Y1.46 bln
Per share
Earnings Y59.11 Y103.73
Results are based on Japanese accounting standards.
This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.
(END) Dow Jones Newswires
October 15, 2025 02:40 ET (06:40 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments